Literature DB >> 20010144

Recognition and management of the infant with Beckwith-Wiedemann Syndrome.

Pamela S Spivey1, Wanda T Bradshaw.   

Abstract

Beckwith-Wiedemann Syndrome (BWS) is the most common overgrowth syndrome in infancy. The characteristic findings are macroglossia, abdominal wall defects, and macrosomia. Genetic studies in infants with BWS demonstrate 3 major subgroups of patients: familial, sporadic, or chromosomally abnormal. Recognition in the neonatal period is important because of the high incidence of childhood malignant tumors associated with BWS. This article provides an overview of the syndrome and discusses its etiology, physical findings, and diagnostic evaluation. Management and clinical implications including family support will also be discussed.

Entities:  

Mesh:

Year:  2009        PMID: 20010144     DOI: 10.1097/ANC.0b013e3181c2003f

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  4 in total

Review 1.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 2.  Hepatobiliary and pancreatic imaging in children-techniques and an overview of non-neoplastic disease entities.

Authors:  Rutger A J Nievelstein; Simon G F Robben; Johan G Blickman
Journal:  Pediatr Radiol       Date:  2010-10-22

3.  Virginal breast hypertrophy in a patient with Beckwith-Wiedemann syndrome.

Authors:  Edyta Szymańska; Elżbieta Moszczyńska; Dariusz Polnik; Sylwia Szymańska; Elżbieta Jurkiewicz; Michał Pyzlak; Michał Armata; Małgorzata Walewska-Wolf; Piotr Kaliciński; Dariusz Rokicki; Mieczysław Szalecki
Journal:  Clin Case Rep       Date:  2018-01-26

4.  Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia.

Authors:  Hiba Al-Zubeidi; Michael E Gottschalk; Ron S Newfield
Journal:  Int J Pediatr Endocrinol       Date:  2014-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.